Jazz Pharmaceuticals PLC
Change company Symbol lookup
Select an option...
JAZZ Jazz Pharmaceuticals PLC
TECK Teck Resources Ltd
BCBNF Base Carbon Inc
PAVM PAVmed Inc
HTGC Hercules Capital Inc
NRG NRG Energy Inc
NLTX Neoleukin Therapeutics Inc
AROW Arrow Financial Corp
EQ Equillium Inc
WSFS WSFS Financial Corp
Go

Health Care : Pharmaceuticals | Mid Cap Value
Based in Ireland
Company profile

Jazz Pharmaceuticals Public Limited Company is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The Company's lead marketed products include Xyrem (sodium oxybate oral solution) for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; Erwinaze for the treatment of acute lymphoblastic leukemia (ALL), and Defitelio (defibrotide) for the treatment of severe hepatic veno-occlusive disease (VOD). The Company also commercializes Prialt, an intrathecally administered infusion of ziconotide, approved by the FDA for the management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies or intrathecal morphine.

Closing Price
$153.49
Day's Change
2.72 (1.80%)
Bid
--
Ask
--
B/A Size
--
Day's High
153.93
Day's Low
150.47
Volume
(Light)
Volume:
431,566

10-day average volume:
582,846
431,566
  • Prev Close
    150.77
  • Today's Open
    152.10
  • Day's Range
    150.47-153.93
  • Avg Vol (10-day)
    582.8K
  • Last (time)
    4:00p ET 06/24/22
  • Last (size)
    7
  • 52-Wk Range
    117.64 - 186.22
    LowHigh
  • (07/12/21 - 11/30/21)
    17.58%
  • 33.5%
  • Market Cap
    9.6B
  • Shares Outstanding
    62.4M
  • -7.52
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.8
  • 93.95
  • (% of float 05/31/22)
    5.86

Latest News

June 15, 2022
10:33 am ET
MarketWatch
June 14, 2022
10:53 am ET
MarketWatch
June 07, 2022
7:30 am ET
PR Newswire
June 01, 2022
4:15 pm ET
PR Newswire
7:45 am ET
PR Newswire
May 26, 2022
8:50 am ET
PR Newswire
May 09, 2022
7:48 am ET
PR Newswire
7:00 am ET
PR Newswire
May 04, 2022
4:10 pm ET
PR Newswire
4:05 pm ET
PR Newswire
May 03, 2022
4:15 pm ET
PR Newswire
April 20, 2022
4:15 pm ET
PR Newswire
April 08, 2022
1:00 pm ET
PR Newswire
April 07, 2022
8:34 am ET
MarketWatch
March 29, 2022
4:15 pm ET
PR Newswire
February 22, 2021
8:19 am ET
Zacks
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.